mRNA |
myricetin |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |
mRNA |
BRD-K99006945 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
0.0001 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0001 |
mRNA |
UNC0638 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0001 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0001 |
mRNA |
BRD-K11533227 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0002 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0003 |
mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0003 |